Literature DB >> 4311377

RNA synthesis in cells infected with herpes simplex virus. II. Evidence that a class of viral mRNA is derived from a high molecular weight precursor synthesized in the nucleus.

E K Wagner, B Roizman.   

Abstract

Viral RNA extracted from the cytoplasmic polyribosomes of human epidermoid carcinoma no. 2 cells infected with herpes simplex virus (mRNA) had a sedimentation coefficient between 10S and 20S while that from nuclei of infected cells varied in size from 10S to >80S. Estimates of the maximum molecular weight of viral RNA from its sedimentation coefficients suggest that at least 10 per cent of the viral genome is transcribed as a single molecule. The ratio of RNA of different sizes found in the nuclei of cells pulse labeled for 12 minutes was approximately the same as those found in cells labeled for longer intervals implying that either some classes of viral mRNA were made as small molecules or that the large viral RNA molecules were cleaved soon after synthesis. Cytoplasmic mRNA competed to a level of at least 80 per cent in viral DNA-RNA hybridization tests with >50S RNA extracted from nuclei of infected cells. This is consistent with the hypothesis that viral mRNA is produced by cleavage of a large precursor RNA molecule.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4311377      PMCID: PMC223390          DOI: 10.1073/pnas.64.2.626

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Ribonucleic acid synthesis in cells infected with herpes simplex virus. I. Patterns of ribonucleic acid synthesis in productively infected cells.

Authors:  E K Wagner; B Roizman
Journal:  J Virol       Date:  1969-07       Impact factor: 5.103

2.  A quantitative assay for DNA-RNA hybrids with DNA immobilized on a membrane.

Authors:  D Gillespie; S Spiegelman
Journal:  J Mol Biol       Date:  1965-07       Impact factor: 5.469

3.  Acrylamide gel electrophoresis of HeLa cell nucleolar RNA.

Authors:  R A Weinberg; U Loening; M Willems; S Penman
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

4.  Patterns of RNA metabolism in a differentiated cell: a rapidly labeled, unstable 60S RNA with messenger properties in duck erythroblasts.

Authors:  K Scherrer; L Marcaud; F Zajdela; I M London; F Gros
Journal:  Proc Natl Acad Sci U S A       Date:  1966-11       Impact factor: 11.205

5.  Relationship between nuclear giant-size dRNA and microsomal dRNA of rat brain.

Authors:  J Stévenin; P Mandel; M Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

6.  High molecular weight nonribosomal-type nuclear RNA and cytoplasmic messenger RNA in HeLa cells.

Authors:  J F Houssais; G Attardi
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

7.  Preparation of mammalian polyribosomes with the detergent Nonidet P-40.

Authors:  T W Borun; M D Scharff; E Robbins
Journal:  Biochim Biophys Acta       Date:  1967-11-21

8.  Arrested protein synthesis in polysomes of cultured chick embryo cells.

Authors:  R Soeiro; H Amos
Journal:  Science       Date:  1966-11-04       Impact factor: 47.728

9.  Ribosomal RNA synthesis and processing in a particulate site in the HeLa cell nucleus.

Authors:  S Penman; I Smith; E Holtzman
Journal:  Science       Date:  1966-11-11       Impact factor: 47.728

10.  Rapidly labeled HeLa cell nuclear RNA. I. Identification by zone sedimentation of a heterogeneous fraction separate from ribosomal precursor RNA.

Authors:  J R Warner; R Soeiro; H C Birnboim; M Girard; J E Darnell
Journal:  J Mol Biol       Date:  1966-08       Impact factor: 5.469

View more
  15 in total

1.  Regulation of herpesvirus macromolecular synthesis. VIII. The transcription program consists of three phases during which both extent of transcription and accumulation of RNA in the cytoplasm are regulated.

Authors:  P C Jones; B Roizman
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

2.  Anatomy of herpes simplex virus DNA VII. alpha-RNA is homologous to noncontiguous sites in both the L and S components of viral DNA.

Authors:  P C Jones; G S Hayward; B Roizman
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

3.  Transcriptional complexity of vaccinia virus in vivo and in vitro.

Authors:  E Paoletti; L J Grady
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

4.  Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins.

Authors:  R W Honess; B Roizman
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

5.  Nuclear ribonucleoprotein complexes containing polyadenylate from mouse ascites cells.

Authors:  T J Quinlan; P B Billings; T E Martin
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

6.  Transcription of the herpes simplex virus genome in human cells.

Authors:  E K Wagner; R I Swanstrom; M G Stafford
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

7.  Adenovirus messenger RNA in mammalian cells: failure of polyribosome association in the absence of nuclear cleavage.

Authors:  P M McGuire; C Swart; L D Hodge
Journal:  Proc Natl Acad Sci U S A       Date:  1972-06       Impact factor: 11.205

8.  Relationship between post-transcriptional adenylation of herpes virus RNA and messenger RNA abundance.

Authors:  S Silverstein; S L Bachenheimer; N Frenkel; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

9.  Nuclear processing of viral high-molecular-weight RNA in cells infected with herpes simplex virus type 1.

Authors:  B Jacquemont; A Garcia; J Huppert
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

10.  RNA synthesis in cells infected with herpes simplex virus. XII. Sequence complexity and properties of RNA differing in extent of adenylation.

Authors:  S Silvertien; R Millette; P Jones; B Roizman
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.